Scancell Share Discussion Threads

[markingtime] 30/3/2023 11:55

15.42 is close to 15.50, not 15.00Good enough, though.....

[markingtime] 30/3/2023 11:53

Thanks for the correct spot re size. I didn't do investment management courses for nothing ;-)I must, however, point out that the fact that trading this share has, ex-post, proven better than buy and hold over the last 10+ years does NOT mean that buy and hold is wrong. Redmile, for instance, is "buy and hold". So am I, with respect to this share. Most traders will have missed the gap up from 12p late last year - or jumped in too late and then got stopped out. Many will also have failed to sell the recent highs and/or re-establish at 15.25p.Crystal ball insights aren't going to cover newsflow....

[tosh123] 30/3/2023 11:49

" Ruck didn't hit target ... only the seller "

You have got to laugh !!!

Ruck got to within £0.004 of his predicted price.

Whereas

The idiot Ineptico, got to within a massive £7.846 of his ... and yet he still tries to claim some kind of victory.

What a buffoon !

[moljen] 30/3/2023 11:22

MT got close to 15p yesterday with a little average up

29/03/2023 Scancell Holdings Plc Ord Shs 0.1p SIPP 12,968.0000 0.1542 £2,000.00 1.0000 Buy Trade

[inanaco] 30/3/2023 11:16

I failed to buy at 15p ... instead, HVO i could buy at 15p .... but didn't

Those describing todays "near Miss" as a 15p buy are being disingenuous to those that couldn't ...

Ruck didn't hit target ... only the seller

[tosh123] 30/3/2023 10:43

Good morning Marking Time,
as you and Ruck quite rightly point out, there has been an opportunity to trade the share over the last few weeks, BUT, this is not the first time that this has happened, in fact there have been numerous opportunities over the past 10 years, all of which go to prove that " buy and hold " ethos is fundamentally flawed.

Also, your " correctly sized " comment resonates with me and shows an educated approach to investing.

[markingtime] 30/3/2023 09:56

Sorry for editing error.

[markingtime] 30/3/2023 09:55

Yes. In this instance that would be right, I expect - at least the entry point has serendipitously improved, thanks to But, as you know, it is all about entry and exit points. I get a bit irritated with people who point to untradable prices in an effort to overclaim that "their approach" is better.Fact is that the pullback was due to the option exercise and sale coinciding with Modi trial news expectations having got ahead of events.

[ruckrover] 30/3/2023 09:42

MT,So basically a trader can make more in two weeks than a LTH has made in 11 years here.

[markingtime] 30/3/2023 09:17

Final comment.....there's a quick 25-30% available here over the next two weeks for traders. I'd be surprised if the price isn't back at 21p or so, pre-conference... ....especially if the overall market continues to take advantage if the recent irrational panic.Personally I'm doing nothing, as I'm correctly-sized. It seems to have been a slack time at the car park though.....I guess we blame the weather ;-)

[markingtime] 30/3/2023 08:32

....my bet is nothing (unless you are a marketmaker)

[markingtime] 30/3/2023 08:27

....so how much did anyone buy at 15p?.....

[tosh123] 29/3/2023 17:53

and as predicted by a couple of people on here, we're back to 15p, which is a million miles away from the resident idiots £8, 5 year old predictions.

Funny how he disappears when he's proven to be wrong and other far more knowledgeable posters are proven to be correct .... yet again !

What a clown !

[panama7] 29/3/2023 17:26

Marcus, you're right it is now 15p, didn't some Posters predict 15p a while ago and weren't they vilified and demonised by the cult for doing so. Maybe the T W A T who has been predicting £8 for the last decade would like to apologise, I won't hold my breath. The cult really don't like posers being right when it goes against their narrative. I imagine they are the same cult members who followed the Government and MSM's narrative on Covid.

[marcusl2] 29/3/2023 15:38

01/08/2011 Genmab`s share price was $0.65

14/11/2022 it hit $44


Seagen started at $5. In 2016 it was $30 today it is $203


Biontech 2019 $14 $389 in 2021 and today $125

Let us hope that Scancell sees some nice growth.

[golcheja] 29/3/2023 13:18

The problem Markus is they are keep saying it fir over 12 years. Therefore all becomes yesterday’s news and only handful are paying attention.

[marcusl2] 29/3/2023 08:31

I don`t think we will be staying at 16p after Scancell`s next press release.

Remember what Lindy said

" We are waiting. It is a little too soon but we will go out and shout about it, soon. When we get there there will be huge enthusiasm. It will be the bigger story because we will have achieved what no-one else has achieved. When you are the first it is tougher.

[torquayfan] 29/3/2023 00:50

Marcus - have Boehringer spotted the Holy Grail or has Prof. Lindy ? ! ? !

Thanks for your recent posts about the Modi 1 progress. After the usual objections, this was my last attempt at a perspective on it :-

"To recap, it seems we have two interesting snippets - one Patient with H & N cancer and another Patient likely with H & N or Kidney cancer - that's two reports that Modi 1 might be working nicely.

For me this is very interesting and not likely to raise expectations which many of us already hold with some optimism do we not?

These heartfelt insights from the Patients are for me, good to see and no doubt they, the Patients will on reflection, understand the interest here, given that we are invested in the Company that is providing this hope for them.

Thanks also to Marcus for his checking that Modi 1 may be the only vaccine recruiting for these conditions atm

And I too am looking forward to the Modi 1 update April 18th latest.

That's that. GLA "

Onwards then

[marcusl2] 28/3/2023 16:28

Boehringer Ingelheim has spied an opportunity to seize the holy grail of immuno-oncology: turning cold tumours hot. In return for $10 million upfront and up to $471 million milestones.

The idea is that deleting ADAR1 could sensitize tumors to immunotherapy and thereby enable more patients to benefit from highly effective drugs such as checkpoint inhibitors.

[marcusl2] 28/3/2023 10:43

I have searched for TNBC, renal

The only cancer vaccine in the UK recruiting is Modi-1.


There is one in Head and neck from Biontech .


and one for Ovarian (which obviously is not him) from Oxford Vacmedix UK Ltd.



It could be a different cancer but good to hear of a vaccine working so well.

[marcusl2] 28/3/2023 10:27

If it is Modi

I am thinking that TF although there is a small chance of Male triple negative breast cancer (TNBC) which is less than 1% of cases.

Great news for him.

[fast lane] 28/3/2023 09:34

In 2018, EcoHealth Alliance asked DARPA for money to insert a furin cleavage site at the S1, S2 junction of a coronavirus at the Wuhan lab.


In 2019, the first coronavirus to ever contain a furin cleavage site at the S1, S2 junction emerged in Wuhan, China.

[torquayfan] 28/3/2023 09:26

Yes thanks Marcus and apologies Guys for the misread - Botski has kindly pointed that out too. So Marcus we can assume her Husband has either head and neck or kidney cancer. Good luck to them both. ATB

[marcusl2] 28/3/2023 08:40

Looking forward to the next update from Scancell. If the response rate seen so far has continued then I think we have a hugely valuable asset and tremendous hope for people with cancer.


Remember the response rate of interest is 25% with only Modi-1 and 45% with Modi-1 plus CPI.

We were at 57.143% response rate and that was mostly for Ovarian which is Modi-1 alone Which needs 25%.


14 patients evaluated; of these 14, one has had a partial response and seven have stable disease.

These data drive increased confidence in the Moditope platform, leading to an uplift in our rNPV valuation to £300.1m, or 36.7p